These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34631755)

  • 21. Evaluation of serum uric acid levels in psoriasis vulgaris.
    Yilmaz E; Tamer E; Artüz F; Külcü Çakmak S; Köktürk F
    Turk J Med Sci; 2017 Apr; 47(2):531-534. PubMed ID: 28425242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gout as a systemic disease. Manifestations, complications and comorbidities of hyperuricaemia].
    Tausche AK; Manger B; Müller-Ladner U; Schmidt B
    Z Rheumatol; 2012 Apr; 71(3):224-30. PubMed ID: 22415625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease.
    Chimenti MS; Caso F; Alivernini S; De Martino E; Costa L; Tolusso B; Triggianese P; Conigliaro P; Gremese E; Scarpa R; Perricone R
    Autoimmun Rev; 2019 Jun; 18(6):565-575. PubMed ID: 30959209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why focus on uric acid?
    Johnson RJ
    Curr Med Res Opin; 2015; 31 Suppl 2():3-7. PubMed ID: 26414730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
    Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
    Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uric acid and cardiovascular diseases: a reappraisal.
    Prabhakar AP; Lopez-Candales A
    Postgrad Med; 2024 Jul; ():1-9. PubMed ID: 38973128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gout and cardiovascular risk].
    Němec P
    Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with psoriatic arthritis have higher levels of FeNO than those with only psoriasis, which may reflect a higher prevalence of a subclinical respiratory involvement.
    Damiani G; Pacifico A; Rizzi M; Santus P; Bridgewood C; Bragazzi NL; Adawi M; Watad A
    Clin Rheumatol; 2020 Oct; 39(10):2981-2988. PubMed ID: 32240433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy.
    Gupta MK; Singh JA
    Drugs; 2019 Apr; 79(5):531-541. PubMed ID: 30868398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances on uric acid transporters.
    Xu L; Shi Y; Zhuang S; Liu N
    Oncotarget; 2017 Nov; 8(59):100852-100862. PubMed ID: 29246027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review.
    Jalal DI
    Curr Med Res Opin; 2016 Nov; 32(11):1863-1869. PubMed ID: 27470664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic tophaceous gout in patients with psoriasis.
    Lobato LC; Coutinho JC; Frota MZ; Schettini AP; Santos M
    An Bras Dermatol; 2017; 92(1):104-106. PubMed ID: 28225966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Uric acid levels of the serum of healthy persons and patients with various rheumatic diseases].
    Bośmanský K; Ondrasík M
    Ter Arkh; 1987; 59(4):22-5. PubMed ID: 3495897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis.
    Cooksey R; Brophy S; Kennedy J; Gutierrez FF; Pickles T; Davies R; Piguet V; Choy E
    Semin Arthritis Rheum; 2018 Dec; 48(3):367-373. PubMed ID: 29656791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperuricemia and Cardiovascular Disease.
    Zhang S; Wang Y; Cheng J; Huangfu N; Zhao R; Xu Z; Zhang F; Zheng W; Zhang D
    Curr Pharm Des; 2019; 25(6):700-709. PubMed ID: 30961478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal arthritides - gout and calcium pyrophosphate arthritis : Part 2: clinical features, diagnosis and differential diagnostics.
    Schlee S; Bollheimer LC; Bertsch T; Sieber CC; Härle P
    Z Gerontol Geriatr; 2018 Jul; 51(5):579-584. PubMed ID: 28233118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of psoriatic arthritis among cutaneous psoriasis patients: from pathogenesis to therapy.
    Hoelt P; Confavreux C; Jullien D; Villani AP
    G Ital Dermatol Venereol; 2017 Oct; 152(5):458-473. PubMed ID: 28534601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular risk in psoriatic arthritis, a narrative review.
    Verhoeven F; Prati C; Demougeot C; Wendling D
    Joint Bone Spine; 2020 Oct; 87(5):413-418. PubMed ID: 31958573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tophaceous gout in plurimetabolic syndrome].
    Iannello S; Cavaliere G; Ferro G; Giuffrì MV; Impellizzieri D; Incognito C; Lizzio G; Neri S; Rapisarda A; Belfiore F
    Minerva Med; 1998; 89(11-12):419-37. PubMed ID: 10212666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.